Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

ACA vs SPIR

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
ACA
Arcosa, Inc.

Industrial - Infrastructure Operations

IndustrialsNYSE • US
Market Cap$6.10B
5Y Perf.+139.2%
SPIR
Spire Global, Inc.

Specialty Business Services

IndustrialsNYSE • US
Market Cap$665.73B
5Y Perf.-74.6%

ACA vs SPIR — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
ACA logoACA
SPIR logoSPIR
IndustryIndustrial - Infrastructure OperationsSpecialty Business Services
Market Cap$6.10B$665.73B
Revenue (TTM)$2.82B$64M
Net Income (TTM)$223M$49M
Gross Margin22.8%42.1%
Operating Margin10.1%-122.0%
Forward P/E29.1x13.4x
Total Debt$1.52B$13M
Cash & Equiv.$215M$25M

ACA vs SPIRLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

ACA
SPIR
StockNov 20May 26Return
Arcosa, Inc. (ACA)100239.2+139.2%
Spire Global, Inc. (SPIR)10025.4-74.6%

Price return only. Dividends and distributions are not included.

Quick Verdict: ACA vs SPIR

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: ACA leads in 4 of 7 categories, making it the strongest pick for growth and revenue expansion and capital preservation and lower volatility. Spire Global, Inc. is the stronger pick specifically for valuation and capital efficiency and profitability and margin quality. As sector peers, any of these can serve as alternatives in the same allocation.
ACA
Arcosa, Inc.
The Income Pick

ACA carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • Dividend streak 1 yrs, beta 1.42, yield 0.2%
  • Rev growth 12.2%, EPS growth 122.0%, 3Y rev CAGR 8.7%
  • 5.1% 10Y total return vs SPIR's -73.7%
Best for: income & stability and growth exposure
SPIR
Spire Global, Inc.
The Value Play

SPIR is the clearest fit if your priority is value and quality.

  • Lower P/E (13.4x vs 29.1x)
  • 76.4% margin vs ACA's 7.9%
  • +70.6% vs ACA's +40.8%
Best for: value and quality
See the full category breakdown
CategoryWinnerWhy
GrowthACA logoACA12.2% revenue growth vs SPIR's -35.2%
ValueSPIR logoSPIRLower P/E (13.4x vs 29.1x)
Quality / MarginsSPIR logoSPIR76.4% margin vs ACA's 7.9%
Stability / SafetyACA logoACABeta 1.42 vs SPIR's 3.29
DividendsACA logoACA0.2% yield; 1-year raise streak; the other pay no meaningful dividend
Momentum (1Y)SPIR logoSPIR+70.6% vs ACA's +40.8%
Efficiency (ROA)ACA logoACA4.5% ROA vs SPIR's 0.1%, ROIC 6.4% vs -71.6%

ACA vs SPIR — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

ACAArcosa, Inc.
FY 2025
Construction Products
45.4%$1.3B
Engineered Structures
41.3%$1.2B
Transportation Products
13.3%$383M
SPIRSpire Global, Inc.

Segment breakdown not available.

ACA vs SPIR — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLACALAGGINGSPIR

Income & Cash Flow (Last 12 Months)

Evenly matched — ACA and SPIR each lead in 3 of 6 comparable metrics.

ACA is the larger business by revenue, generating $2.8B annually — 44.5x SPIR's $64M. SPIR is the more profitable business, keeping 76.4% of every revenue dollar as net income compared to ACA's 7.9%. On growth, ACA holds the edge at -9.5% YoY revenue growth, suggesting stronger near-term business momentum.

MetricACA logoACAArcosa, Inc.SPIR logoSPIRSpire Global, Inc.
RevenueTrailing 12 months$2.8B$64M
EBITDAEarnings before interest/tax$456M-$63M
Net IncomeAfter-tax profit$223M$49M
Free Cash FlowCash after capex$225M-$119M
Gross MarginGross profit ÷ Revenue+22.8%+42.1%
Operating MarginEBIT ÷ Revenue+10.1%-122.0%
Net MarginNet income ÷ Revenue+7.9%+76.4%
FCF MarginFCF ÷ Revenue+8.0%-186.7%
Rev. Growth (YoY)Latest quarter vs prior year-9.5%-33.7%
EPS Growth (YoY)Latest quarter vs prior year-37.5%-1.3%
Evenly matched — ACA and SPIR each lead in 3 of 6 comparable metrics.

Valuation Metrics

ACA leads this category, winning 2 of 3 comparable metrics.

At 13.4x trailing earnings, SPIR trades at a 54% valuation discount to ACA's 29.3x P/E.

MetricACA logoACAArcosa, Inc.SPIR logoSPIRSpire Global, Inc.
Market CapShares × price$6.1B$665.7B
Enterprise ValueMkt cap + debt − cash$7.4B$665.7B
Trailing P/EPrice ÷ TTM EPS29.28x13.43x
Forward P/EPrice ÷ next-FY EPS est.29.15x
PEG RatioP/E ÷ EPS growth rate2.06x
EV / EBITDAEnterprise value multiple13.15x
Price / SalesMarket cap ÷ Revenue2.11x9303.95x
Price / BookPrice ÷ Book value/share2.32x5662.14x
Price / FCFMarket cap ÷ FCF34.73x
ACA leads this category, winning 2 of 3 comparable metrics.

Profitability & Efficiency

ACA leads this category, winning 5 of 9 comparable metrics.

ACA delivers a 8.6% return on equity — every $100 of shareholder capital generates $9 in annual profit, vs $0 for SPIR. SPIR carries lower financial leverage with a 0.12x debt-to-equity ratio, signaling a more conservative balance sheet compared to ACA's 0.58x. On the Piotroski fundamental quality scale (0–9), ACA scores 8/9 vs SPIR's 5/9, reflecting strong financial health.

MetricACA logoACAArcosa, Inc.SPIR logoSPIRSpire Global, Inc.
ROE (TTM)Return on equity+8.6%+0.2%
ROA (TTM)Return on assets+4.5%+0.1%
ROICReturn on invested capital+6.4%-71.6%
ROCEReturn on capital employed+7.8%-96.1%
Piotroski ScoreFundamental quality 0–985
Debt / EquityFinancial leverage0.58x0.12x
Net DebtTotal debt minus cash$1.3B-$11M
Cash & Equiv.Liquid assets$215M$25M
Total DebtShort + long-term debt$1.5B$13M
Interest CoverageEBIT ÷ Interest expense2.76x37.30x
ACA leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

SPIR leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in ACA five years ago would be worth $20,090 today (with dividends reinvested), compared to $2,532 for SPIR. Over the past 12 months, SPIR leads with a +70.6% total return vs ACA's +40.8%. The 3-year compound annual growth rate (CAGR) favors SPIR at 51.4% vs ACA's 22.0% — a key indicator of consistent wealth creation.

MetricACA logoACAArcosa, Inc.SPIR logoSPIRSpire Global, Inc.
YTD ReturnYear-to-date+16.3%+156.2%
1-Year ReturnPast 12 months+40.8%+70.6%
3-Year ReturnCumulative with dividends+81.8%+247.3%
5-Year ReturnCumulative with dividends+100.9%-74.7%
10-Year ReturnCumulative with dividends+509.7%-73.7%
CAGR (3Y)Annualised 3-year return+22.0%+51.4%
SPIR leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

ACA leads this category, winning 2 of 2 comparable metrics.

ACA is the less volatile stock with a 1.42 beta — it tends to amplify market swings less than SPIR's 3.29 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ACA currently trades 91.6% from its 52-week high vs SPIR's 84.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricACA logoACAArcosa, Inc.SPIR logoSPIRSpire Global, Inc.
Beta (5Y)Sensitivity to S&P 5001.42x3.29x
52-Week HighHighest price in past year$135.58$23.59
52-Week LowLowest price in past year$81.91$6.60
% of 52W HighCurrent price vs 52-week peak+91.6%+84.8%
RSI (14)Momentum oscillator 0–10064.353.7
Avg Volume (50D)Average daily shares traded286K1.8M
ACA leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Wall Street rates ACA as "Buy" and SPIR as "Buy". Consensus price targets imply 12.8% upside for ACA (target: $140) vs -1.9% for SPIR (target: $20). ACA is the only dividend payer here at 0.16% yield — a key consideration for income-focused portfolios.

MetricACA logoACAArcosa, Inc.SPIR logoSPIRSpire Global, Inc.
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$140.00$19.63
# AnalystsCovering analysts812
Dividend YieldAnnual dividend ÷ price+0.2%
Dividend StreakConsecutive years of raises1
Dividend / ShareAnnual DPS$0.20
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%
Insufficient data to determine a leader in this category.
Key Takeaway

ACA leads in 3 of 6 categories (Valuation Metrics, Profitability & Efficiency). SPIR leads in 1 (Total Returns). 1 tied.

Best OverallArcosa, Inc. (ACA)Leads 3 of 6 categories
Loading custom metrics...

ACA vs SPIR: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is ACA or SPIR a better buy right now?

For growth investors, Arcosa, Inc.

(ACA) is the stronger pick with 12. 2% revenue growth year-over-year, versus -35. 2% for Spire Global, Inc. (SPIR). Spire Global, Inc. (SPIR) offers the better valuation at 13. 4x trailing P/E, making it the more compelling value choice. Analysts rate Arcosa, Inc. (ACA) a "Buy" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — ACA or SPIR?

On trailing P/E, Spire Global, Inc.

(SPIR) is the cheapest at 13. 4x versus Arcosa, Inc. at 29. 3x.

03

Which is the better long-term investment — ACA or SPIR?

Over the past 5 years, Arcosa, Inc.

(ACA) delivered a total return of +100. 9%, compared to -74. 7% for Spire Global, Inc. (SPIR). Over 10 years, the gap is even starker: ACA returned +509. 7% versus SPIR's -73. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — ACA or SPIR?

By beta (market sensitivity over 5 years), Arcosa, Inc.

(ACA) is the lower-risk stock at 1. 42β versus Spire Global, Inc. 's 3. 29β — meaning SPIR is approximately 131% more volatile than ACA relative to the S&P 500. On balance sheet safety, Spire Global, Inc. (SPIR) carries a lower debt/equity ratio of 12% versus 58% for Arcosa, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — ACA or SPIR?

By revenue growth (latest reported year), Arcosa, Inc.

(ACA) is pulling ahead at 12. 2% versus -35. 2% for Spire Global, Inc. (SPIR). On earnings-per-share growth, the picture is similar: Spire Global, Inc. grew EPS 135. 0% year-over-year, compared to 122. 0% for Arcosa, Inc.. Over a 3-year CAGR, ACA leads at 8. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — ACA or SPIR?

Spire Global, Inc.

(SPIR) is the more profitable company, earning 71. 7% net margin versus 7. 2% for Arcosa, Inc. — meaning it keeps 71. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ACA leads at 11. 8% versus -121. 4% for SPIR. At the gross margin level — before operating expenses — SPIR leads at 40. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is ACA or SPIR more undervalued right now?

Analyst consensus price targets imply the most upside for ACA: 12.

8% to $140. 00.

08

Which pays a better dividend — ACA or SPIR?

In this comparison, ACA (0.

2% yield) pays a dividend. SPIR does not pay a meaningful dividend and should not be held primarily for income.

09

Is ACA or SPIR better for a retirement portfolio?

For long-horizon retirement investors, Arcosa, Inc.

(ACA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+509. 7% 10Y return). Spire Global, Inc. (SPIR) carries a higher beta of 3. 29 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ACA: +509. 7%, SPIR: -73. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between ACA and SPIR?

Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: ACA is a small-cap quality compounder stock; SPIR is a large-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

ACA

Quality Business

  • Sector: Industrials
  • Market Cap > $100B
  • Net Margin > 5%
Run This Screen
Stocks Like

SPIR

Quality Mega-Cap Compounder

  • Sector: Industrials
  • Market Cap > $100B
  • Net Margin > 45%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform ACA and SPIR on the metrics below

Revenue Growth>
%
(ACA: -9.5% · SPIR: -33.7%)
Net Margin>
%
(ACA: 7.9% · SPIR: 76.4%)
P/E Ratio<
x
(ACA: 29.3x · SPIR: 13.4x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.